India approves Novo Nordisk’s obesity drug Wegovy for fatty liver disease
July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug Wegovy for the treatment of...
Read the full articleJuly 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug Wegovy for the treatment of...
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.